/CGEM

Cullinan Therapeutics Inc

CGEM

$20.59USD↓-1.95%-0.41 today

MARKET CAP

1.3B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$20 – $21

52W RANGE

$6

$23

AI Summary

Stalk

StalkMedium

CGEM is in a Stage 2 advancing structure, supported by a Bearish Exhaustion pattern suggesting sellers are losing control. However, the recent pullback through the rising 9 and 20 EMAs signals weakening short-term momentum. Price remains above the rising 50 SMA and 200 DMA, and RSI and Options Score are neutral, offering no immediate timing edge. Execution should be deferred until a shallow pullback is absorbed at the dynamic EMA support zone, confirming continued trend validity. A decisive close below the 50 SMA would invalidate the medium-term bullish bias.

↑Phase 3 trial for zipalertinib in NSCLC met primary PFS endpoint.
↑Six analysts rate CGEM a Buy with an average price target of $32.14.
↓Deep losses: adjusted Q2 EPS of –$0.81 vs –$0.80 estimate.

Full analysis →

Buying

9

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	5.23 M	95.29 M	+782.80 K	+50.7%	0.00%
RI Rtw Investments, LP Q2 2026	BUY	2.36 M	43.05 M	+658.39 K	+77.6%	0.37%
AC Aqr Capital Management LLC Q2 2026	BUY	581.34 K	10.59 M	+220.46 K	+106.4%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	513.18 K	9.35 M	+220.81 K	+124.9%	0.00%
PA Perceptive Advisors LLC Q2 2026	BUYNEW	426.48 K	7.77 M	+426.48 K	+0.0%	0.12%
MM Millennium Management LLC Q2 2026	SELL	366.23 K	6.67 M	+-350.00	+28.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	326.81 K	5.95 M	+2.70 K	+29.2%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	282.63 K	5.21 M	+-14.60 K	+30.5%	0.00%
MC Moore Capital Management, LP Q2 2026	BUY	189.95 K	3.46 M	+83.99 K	+129.7%	0.05%
PA Point72 Asset Management, L.P. Q2 2026	SELL	75.01 K	1.37 M	+-830.37 K	-89.4%	0.00%
FA Fisher Asset Management, LLC Q2 2026	BUYNEW	36.00 K	655.52 K	+36.00 K	+0.0%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	37.06 K	526.38 K	+18.53 K	+175.0%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	SELL	0.00	0.00	+-50.00 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-24.08 K	-100.0%	0.00%